On August 30, 2018 IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") reported that its Chief Financial Officer, Andre Godin, is scheduled to present at the Rodman & Renshaw 20th Annual Global Investment Conference on September 6, 2018 at 2:35 p.m. Eastern Time at the St. Regis New York (Press release, IntelGenx, AUG 30, 2018, View Source;Renshaw-Global-Investment-Conference/default.aspx [SID1234529179]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Godin will provide an overview of IntelGenx’s business during the presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

The presentation will be webcast live and archived for 90 days on the Company’s website, www.intelgenx.com, under "Investors".